The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia

Conditions

• Barrett's Oesophagus

Interventions

• DIAGNOSTIC_TEST: Cytosponge test
• DIAGNOSTIC_TEST: Assessment of the panel of molecular biomarkers: IM-SCORE, TFF3 protein expression, methylation panel, p53 mutation
• DIAGNOSTIC_TEST: Oesophagogastroduodenoscopy

Sponsor

University of Cambridge

Collaborators

• [object Object]